Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial.

MiltonPacker; FaiezZannad; JavedButler; GerasimosFilippatos; Joao PedroFerreira; Stuart JPocock; MartinaBrueckmann; CordulaZeller; SibylleHauske; Stefan DAnker; +1 more... EMPEROR-Preserved Trial Study Group; EMPEROR-Preserved Trial Study Group; (2021) Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial. European journal of heart failure, 23 (10). pp. 1798-1799. ISSN 1388-9842 DOI: 10.1002/ejhf.2334
Copy

RESEARCH LETTER - No abstract available.
Item Type Article
Elements ID 165863

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads

picture_as_pdf
ejhf.2334.pdf
subject
Published Version
Available under Creative Commons: 3.0
View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: